BxC-I17e
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BxC-I17e, covering 2024-08-09 to 2025-09-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis [Phase 1]